acknowledges funding support from a BBSRC Industry Case Partnership with GSK (BB/L502273/2), J.L
The GLP-1 Cost Problem: Bigger Than Most Employers Realize GLP-1 receptor agonists like Ozempic, Wegovy, Mounjaro, and Zepbound have reshaped the treatment landscape for both diabetes and obesity
The only primary-source injectable AHK-Cu-class dose range animal / formulation data, not a human trial
Probiotics: Contain beneficial bacteria that may help restore balance to your gut flora
Our bodies are constantly exposed to pollutants and pesticides, as well as the genetic modifications added to the animal foods we consume
Last reviewed: July 3, 2026 Last updated: July 3, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations